These results are consistent with a previous report that PLK1 activity is necessary for mitotic entry from G2/M arrest induced by DNA damage [41], and indicate that GSK461364-mediated PLK inhibition prevents neuroblastoma cell cycle progression. The gene discussed is PLK1; the disease is neuroblastoma.